Dynamics of Anti-HBc Serology During Anti-CD20 Therapy: Incidence, Timing, and Predictors of Anti-HBc Seroclearance in a Retrospective Cohort.

Eren F, Celik MA, Akduman R, Yasar M, Goktug MR, Ocakoglu G, Gurel S

Open source

DOI
10.3390/medicina62091659
Published
2026 Aug 29
Container
Medicina (Kaunas, Lithuania)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/medicina62091659,
  title = {Dynamics of Anti-HBc Serology During Anti-CD20 Therapy: Incidence, Timing, and Predictors of Anti-HBc Seroclearance in a Retrospective Cohort.},
  author = {Eren F and Celik MA and Akduman R and Yasar M and Goktug MR and Ocakoglu G and Gurel S},
  year = {2026},
  journal = {Medicina (Kaunas, Lithuania)},
  doi = {10.3390/medicina62091659},
  url = {https://doi.org/10.3390/medicina62091659}
}

RIS

TY  - JOUR
TI  - Dynamics of Anti-HBc Serology During Anti-CD20 Therapy: Incidence, Timing, and Predictors of Anti-HBc Seroclearance in a Retrospective Cohort.
AU  - Eren F
AU  - Celik MA
AU  - Akduman R
AU  - Yasar M
AU  - Goktug MR
AU  - Ocakoglu G
AU  - Gurel S
PY  - 2026
JO  - Medicina (Kaunas, Lithuania)
DO  - 10.3390/medicina62091659
UR  - https://doi.org/10.3390/medicina62091659
ER  - 

APA

F, E., MA, C., R, A., M, Y., MR, G., G, O., & S, G. (2026). Dynamics of Anti-HBc Serology During Anti-CD20 Therapy: Incidence, Timing, and Predictors of Anti-HBc Seroclearance in a Retrospective Cohort.. Medicina (Kaunas, Lithuania). https://doi.org/10.3390/medicina62091659

Source records